PLEASANTON, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fiscal 2008 year on Thursday, February 5.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Standard Time (4:30 p.m., Eastern Standard Time), Thursday, February 5, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief financial officer.
The teleconference can be accessed by calling (719) 325-2390, passcode 7541788. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=95989&eventID=2073636 or at http://www.thoratec.com/.
A replay of the conference call will be available through Thursday, February 12, via http://www.thoratec.com/ or by telephone at (719) 457-0820, passcode 7541788.
Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com/ or http://www.itcmed.com/.
